Tocilizumab for treatment of mechanically ventilated patients with COVID-19
EC Somers, GA Eschenauer, JP Troost… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe coronavirus disease 2019 (COVID-19) can manifest in rapid
decompensation and respiratory failure with elevated inflammatory markers, consistent with …
decompensation and respiratory failure with elevated inflammatory markers, consistent with …
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
EC Somers, GA Eschenauer, JP Troost, JL Golob… - medRxiv, 2020 - medrxiv.org
Background Severe COVID-19 can manifest in rapid decompensation and respiratory failure
with elevated inflammatory markers. This presentation is consistent with cytokine release …
with elevated inflammatory markers. This presentation is consistent with cytokine release …
[PDF][PDF] Tocilizumab for treatment of mechanically ventilated patients with COVID-19
EC Somers - Ann Arbor, 2020 - scholar.archive.org
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. This is an Open Access article …
University Press for the Infectious Diseases Society of America. This is an Open Access article …
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
EC Somers, GA Eschenauer… - … publication of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Severe coronavirus disease 2019 (COVID-19) can manifest in rapid
decompensation and respiratory failure with elevated inflammatory markers, consistent with …
decompensation and respiratory failure with elevated inflammatory markers, consistent with …
[PDF][PDF] Tocilizumab for treatment of mechanically ventilated patients with COVID-19
EC Somers - Ann Arbor, 2020 - natap.org
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. This is an Open Access article …
University Press for the Infectious Diseases Society of America. This is an Open Access article …
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
EC Somers, GA Eschenauer, JP Troost… - Clinical Infectious …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Severe coronavirus disease 2019 (COVID-19) can manifest in rapid decompensation and …
Severe coronavirus disease 2019 (COVID-19) can manifest in rapid decompensation and …
[PDF][PDF] Tocilizumab for treatment of mechanically ventilated patients with COVID-19
EC Somers - Ann Arbor - scienceopen.com
Background Severe COVID-19 can manifest in rapid decompensation and respiratory failure
with elevated inflammatory markers. This presentation is consistent with cytokine release …
with elevated inflammatory markers. This presentation is consistent with cytokine release …
[HTML][HTML] Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
EC Somers, GA Eschenauer, JP Troost… - … Diseases: An Official …, 2021 - ncbi.nlm.nih.gov
Background Severe coronavirus disease 2019 (COVID-19) can manifest in rapid
decompensation and respiratory failure with elevated inflammatory markers, consistent with …
decompensation and respiratory failure with elevated inflammatory markers, consistent with …
[HTML][HTML] Tocilizumab for treatment of mechanically ventilated patients with COVID-19
EC Somers, GA Eschenauer, JP Troost, JL Golob… - 2020 - europepmc.org
Background Severe COVID-19 can manifest in rapid decompensation and respiratory failure
with elevated inflammatory markers. This presentation is consistent with cytokine release …
with elevated inflammatory markers. This presentation is consistent with cytokine release …
[PDF][PDF] Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
EC Somers, GA Eschenauer, JP Troost… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe coronavirus disease 2019 (COVID-19) can manifest in rapid
decompensation and respiratory failure with elevated inflammatory markers, consistent with …
decompensation and respiratory failure with elevated inflammatory markers, consistent with …